Key Record Dates
ClinicalTrials.gov Identifier: | NCT04398147 |
---|---|
Brief Title: | Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada |
First Submitted : | May 18, 2020 |
First Submitted that Met QC Criteria : | May 18, 2020 |
First Posted : | May 21, 2020 |
Last Update Submitted that Met QC Criteria : | June 30, 2020 |
Last Update Posted : | July 2, 2020 |